Who’s Hired? Rosemont Drives M&A With New Appointments

As EuroAPI Brings In A Chief Transformation Officer To Help Revive Its Fortunes

UK liquids specialist Rosemont Pharmaceuticals has appointed a new chief corporate development officer to drive M&A. Meanwhile, EuroAPI has named a chief transformation officer, Zentiva’s CEO has joined Medicines for Europe’s executive committee, Hikma has changed company secretary, and Xbrane has made alterations to its nominations committee.

Rosemont’s chief corporate development officer will focus on M&A • Source: Shutterstock

More from Leadership

More from Generics Bulletin